Electronic Registry of Male Patients With Congenital Adrenal Hyperplasia 21-hydroxylase Deficiency
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Observational, retrospective, prospective, single-center cohort study. Participation in the registry will be offered consecutively to any patient with the disease, newly diagnosed or with documented diagnosis made at another center, at any stage of the disease. Laboratory tests, imaging study for patient monitoring and care procedures all will be conducted in accordance with normal clinical practice.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Male gender;
• Age 18 years or older;
• Newly or previously diagnosed patients with CAH from 21-hydroxylase enzyme deficiency, in whom CYP21A2 gene analysis for determination of pathological mutations and genotype has already been performed;
• Obtaining informed consent.
Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero Universitaria di Bologna
RECRUITING
Bologna
Contact Information
Primary
Alessandra Gambineri, MD
alessandra.gambineri@aosp.bo.it
+390512144628
Time Frame
Start Date: 2022-06-24
Estimated Completion Date: 2032-12-31
Participants
Target number of participants: 30
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna